Xeris Biopharma Holdings Inc Sustainability Reports
Xeris Biopharma Holdings, Inc. is a commercial-stage biopharmaceutical company that develops and commercializes innovative, ready-to-use injectable and therapies. The company utilizes proprietary technology platforms, XeriSol and XeriJect, to formulate specialist-oriented and rare disease products.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493001EPAB2LX05WW18
FIGI: BBG012V1MG61
3 reports from 2018 to 2022